These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36344069)

  • 21. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
    Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
    Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystic Fibrosis: Pathophysiology of Lung Disease.
    Bergeron C; Cantin AM
    Semin Respir Crit Care Med; 2019 Dec; 40(6):715-726. PubMed ID: 31659725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current evidence on the effect of highly effective CFTR modulation on interleukin-8 in cystic fibrosis.
    Williamson M; Casey M; Gabillard-Lefort C; Alharbi A; Teo YQJ; McElvaney NG; Reeves EP
    Expert Rev Respir Med; 2022 Jan; 16(1):43-56. PubMed ID: 34726115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis.
    Westhölter D; Beckert H; Straßburg S; Welsner M; Sutharsan S; Taube C; Reuter S
    J Cyst Fibros; 2021 Nov; 20(6):1072-1079. PubMed ID: 34030985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
    Kunzelmann K; Mall M
    Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation.
    Ortiz-Muñoz G; Yu MA; Lefrançais E; Mallavia B; Valet C; Tian JJ; Ranucci S; Wang KM; Liu Z; Kwaan N; Dawson D; Kleinhenz ME; Khasawneh FT; Haggie PM; Verkman AS; Looney MR
    J Clin Invest; 2020 Apr; 130(4):2041-2053. PubMed ID: 31961827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections.
    Durfey SL; Pipavath S; Li A; Vo AT; Ratjen A; Carter S; Morgan SJ; Radey MC; Grogan B; Salipante SJ; Welsh MJ; Stoltz DA; Goss CH; McKone EF; Singh PK
    mBio; 2021 Dec; 12(6):e0314821. PubMed ID: 34903059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspergillus infections in cystic fibrosis.
    King J; Brunel SF; Warris A
    J Infect; 2016 Jul; 72 Suppl():S50-5. PubMed ID: 27177733
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Saint-Criq V; Villeret B; Bastaert F; Kheir S; Hatton A; Cazes A; Xing Z; Sermet-Gaudelus I; Garcia-Verdugo I; Edelman A; Sallenave JM
    Thorax; 2018 Jan; 73(1):49-61. PubMed ID: 28790180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy.
    Lommatzsch ST; Taylor-Cousar JL
    Ther Adv Respir Dis; 2019; 13():1753466619844424. PubMed ID: 31027466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of AMP-activated kinase by dysfunctional cystic fibrosis transmembrane conductance regulator in cystic fibrosis airway epithelial cells mitigates excessive inflammation.
    Hallows KR; Fitch AC; Richardson CA; Reynolds PR; Clancy JP; Dagher PC; Witters LA; Kolls JK; Pilewski JM
    J Biol Chem; 2006 Feb; 281(7):4231-41. PubMed ID: 16361706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis: exploiting its genetic basis in the hunt for new therapies.
    Kreindler JL
    Pharmacol Ther; 2010 Feb; 125(2):219-29. PubMed ID: 19903491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Innate immune response in CF airway epithelia: hyperinflammatory?
    Machen TE
    Am J Physiol Cell Physiol; 2006 Aug; 291(2):C218-30. PubMed ID: 16825601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.
    Robledo-Avila FH; Ruiz-Rosado JD; Brockman KL; Kopp BT; Amer AO; McCoy K; Bakaletz LO; Partida-Sanchez S
    J Immunol; 2018 Oct; 201(7):2016-2027. PubMed ID: 30120123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators.
    Perrem L; Ratjen F
    Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S46-S55. PubMed ID: 31715088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into the pathogenesis of cystic fibrosis sinusitis.
    Chang EH
    Int Forum Allergy Rhinol; 2014 Feb; 4(2):132-7. PubMed ID: 24282147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving outcomes of infections in cystic fibrosis in the era of CFTR modulator therapy.
    Saiman L
    Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S18-S26. PubMed ID: 31715086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of
    Meoli A; Eickmeier O; Pisi G; Fainardi V; Zielen S; Esposito S
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron chelation as novel treatment for lung inflammation in cystic fibrosis.
    Aali M; Caldwell A; House K; Zhou J; Chappe V; Lehmann C
    Med Hypotheses; 2017 Jul; 104():86-88. PubMed ID: 28673599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections.
    Hisert KB; Heltshe SL; Pope C; Jorth P; Wu X; Edwards RM; Radey M; Accurso FJ; Wolter DJ; Cooke G; Adam RJ; Carter S; Grogan B; Launspach JL; Donnelly SC; Gallagher CG; Bruce JE; Stoltz DA; Welsh MJ; Hoffman LR; McKone EF; Singh PK
    Am J Respir Crit Care Med; 2017 Jun; 195(12):1617-1628. PubMed ID: 28222269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.